Basic Information
ID: ALA3090138
Type: Functional
Description: Antiviral activity against Western equine encephalomyelitis virus infected in human BE(2)-C cells assessed as reduction of viral titer at 25 uM after 24 hrs by plaque reduction assay (Rvb = 25.7 +/- 5.2 x 10'6 pfu/ml)
Organism: Western equine encephalitis virus
Activity Charts
Bioactivity
Activity Types for Assay ALA3090138
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 244.21 | -3.01 | -3.01 |
| 466.59 | 4.30 | 4.30 |
| 519.02 | 5.09 | 5.09 |
| 502.02 | 4.34 | 4.34 |
| 450.97 | 3.80 | 3.80 |
| 502.02 | 4.34 | 4.34 |
| 500.04 | 6.07 | 6.07 |
| 501.03 | 5.47 | 5.47 |
| 501.03 | 5.47 | 5.47 |
| 501.03 | 4.95 | 4.95 |
| 515.06 | 5.51 | 5.51 |
| 490.01 | 4.21 | 4.21 |